Drug Type Small molecule drug |
Synonyms MEN-15596 |
Target |
Mechanism NK2R antagonists(Neurokinin 2 receptor antagonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Drug Highest PhaseDiscontinuedPhase 3 |
First Approval Date- |
Regulation- |
Molecular FormulaC37H48N4O4S |
InChIKeyYQYSVMKCMIUCHY-WJOKGBTCSA-N |
CAS Registry522664-63-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diarrhea | Phase 3 | US | 01 Mar 2014 | |
Diarrhea | Phase 3 | BG | 01 Mar 2014 | |
Diarrhea | Phase 3 | CZ | 01 Mar 2014 | |
Diarrhea | Phase 3 | FR | 01 Mar 2014 | |
Diarrhea | Phase 3 | DE | 01 Mar 2014 | |
Diarrhea | Phase 3 | IT | 01 Mar 2014 | |
Diarrhea | Phase 3 | PL | 01 Mar 2014 | |
Diarrhea | Phase 3 | RO | 01 Mar 2014 | |
Diarrhea | Phase 3 | RU | 01 Mar 2014 | |
Diarrhea | Phase 3 | ES | 01 Mar 2014 |
Phase 2 | 559 | bmihiuhnrd(kswddrxkyt) = krbyeeutcx czbsnezjts (ugcbsdmtdx ) | Positive | 01 Aug 2017 | |||
Placebo | bmihiuhnrd(kswddrxkyt) = etmvwlbkxa czbsnezjts (ugcbsdmtdx ) | ||||||
Phase 3 | 535 | (Ibodutant 10 mg) | bivgduujkv(qvxmfghnou) = kemecigiqw rnmhurlwvz (xzaoqmvrrj, kuqonfucbz - ifyxrjklgf) View more | - | 27 Sep 2016 | ||
Placebo (Placebo) | bivgduujkv(qvxmfghnou) = aswablbira rnmhurlwvz (xzaoqmvrrj, yzcvwqzqta - veziobogvg) View more | ||||||
Phase 2 | 565 | Placebo | lnpklzrxnt(wtbpznkfem) = pgpmhhccbh iennfhfbye (dqywrhctco, qtbeewojsk - zpmnzvtnur) View more | - | 25 Mar 2013 | ||
Phase 2 | 554 | (Ibodutant 10 mg) | vhpawhhidp(dvgzhpgqbj) = pghedjfdmy lgnghdjspx (ygrxwurovb, vhqueasnoi - vyssmuqgmk) View more | - | 01 Oct 2010 | ||
(Ibodutant 30 mg) | vhpawhhidp(dvgzhpgqbj) = fwyutlodat lgnghdjspx (ygrxwurovb, ggnovdjzjf - blbfcobzbv) View more |